Health agencies in the U.S. and Europe say there’s no evidence that thoughts of suicide or self-harm are linked to the popular weight loss and diabetes drug semaglutide, which is sold under the brand names Ozempic and Wegovy.
Related Posts
Biden officials worry that a ‘frenetic’ Israeli response to Iran’s attack could trigger a wider war
- blkalertshealth
- April 15, 2024
- 0
Some top U.S.
FDA faces backlash over approval of genetic test for opioid addiction risk
- blkalertshealth
- April 5, 2024
- 0
The Food and Drug Administration is facing backlas
New study shows a link between alcohol and heart disease in women
- blkalertshealth
- March 30, 2024
- 0
A new study from Kaiser Permanente of Northern Cal